Global Continuous Glucose Monitoring (CGM) Market Growth 2024-2030
Product Code: 795251
Industry: Medical Devices & Consumables
Published: Jan 02,2024
Pages: 100
Delivery Time: 2-3 business days
Global Continuous Glucose Monitoring (CGM) Market Growth 2024-2030
Product Code: 795251
Industry: Medical Devices & Consumables
Published: Jan 02,2024
Pages: 100
Delivery Time: 2-3 business days
Select A Format
Single User License
USD3660
Multi Users License
USD5490
Corporate Users License
USD7320
Buy Now
Add To Cart
Or More Options：
PDF Download
Sample Request
Custom Request
Description
According to our LPI (LP Information) latest study, the global Continuous Glucose Monitoring (CGM) market size was valued at US$ 4511.7 million in 2023. With growing demand in downstream market, the Continuous Glucose Monitoring (CGM) is forecast to a readjusted size of US$ 5872.7 million by 2030 with a CAGR of 3.8% during review period.
The research report highlights the growth potential of the global Continuous Glucose Monitoring (CGM) market. Continuous Glucose Monitoring (CGM) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Continuous Glucose Monitoring (CGM). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Continuous Glucose Monitoring (CGM) market.
A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Continuous Glucose Monitoring (CGM) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Continuous Glucose Monitoring (CGM) market. It may include historical data, market segmentation by Type (e.g., Transmitters, Sensors), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Continuous Glucose Monitoring (CGM) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Continuous Glucose Monitoring (CGM) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Continuous Glucose Monitoring (CGM) industry. This include advancements in Continuous Glucose Monitoring (CGM) technology, Continuous Glucose Monitoring (CGM) new entrants, Continuous Glucose Monitoring (CGM) new investment, and other innovations that are shaping the future of Continuous Glucose Monitoring (CGM).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Continuous Glucose Monitoring (CGM) market. It includes factors influencing customer ' purchasing decisions, preferences for Continuous Glucose Monitoring (CGM) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Continuous Glucose Monitoring (CGM) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Continuous Glucose Monitoring (CGM) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Continuous Glucose Monitoring (CGM) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Continuous Glucose Monitoring (CGM) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Continuous Glucose Monitoring (CGM) market.
Market Segmentation:
Continuous Glucose Monitoring (CGM) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Transmitters
Sensors
Insulin Pumps
Segmentation by application
Hospitals
Homecare Settings
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens
Key Questions Addressed in this Report
What is the 10-year outlook for the global Continuous Glucose Monitoring (CGM) market?
What factors are driving Continuous Glucose Monitoring (CGM) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Continuous Glucose Monitoring (CGM) market opportunities vary by end market size?
How does Continuous Glucose Monitoring (CGM) break out type, application?
Table Of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Continuous Glucose Monitoring (CGM) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Continuous Glucose Monitoring (CGM) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Continuous Glucose Monitoring (CGM) by Country/Region, 2019, 2023 & 2030
2.2 Continuous Glucose Monitoring (CGM) Segment by Type
2.2.1 Transmitters
2.2.2 Sensors
2.2.3 Insulin Pumps
2.3 Continuous Glucose Monitoring (CGM) Sales by Type
2.3.1 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2019-2024)
2.3.2 Global Continuous Glucose Monitoring (CGM) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Continuous Glucose Monitoring (CGM) Sale Price by Type (2019-2024)
2.4 Continuous Glucose Monitoring (CGM) Segment by Application
2.4.1 Hospitals
2.4.2 Homecare Settings
2.4.3 Others
2.5 Continuous Glucose Monitoring (CGM) Sales by Application
2.5.1 Global Continuous Glucose Monitoring (CGM) Sale Market Share by Application (2019-2024)
2.5.2 Global Continuous Glucose Monitoring (CGM) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Continuous Glucose Monitoring (CGM) Sale Price by Application (2019-2024)
3 Global Continuous Glucose Monitoring (CGM) by Company
3.1 Global Continuous Glucose Monitoring (CGM) Breakdown Data by Company
3.1.1 Global Continuous Glucose Monitoring (CGM) Annual Sales by Company (2019-2024)
3.1.2 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Company (2019-2024)
3.2 Global Continuous Glucose Monitoring (CGM) Annual Revenue by Company (2019-2024)
3.2.1 Global Continuous Glucose Monitoring (CGM) Revenue by Company (2019-2024)
3.2.2 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Company (2019-2024)
3.3 Global Continuous Glucose Monitoring (CGM) Sale Price by Company
3.4 Key Manufacturers Continuous Glucose Monitoring (CGM) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Continuous Glucose Monitoring (CGM) Product Location Distribution
3.4.2 Players Continuous Glucose Monitoring (CGM) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Continuous Glucose Monitoring (CGM) by Geographic Region
4.1 World Historic Continuous Glucose Monitoring (CGM) Market Size by Geographic Region (2019-2024)
4.1.1 Global Continuous Glucose Monitoring (CGM) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Continuous Glucose Monitoring (CGM) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Continuous Glucose Monitoring (CGM) Market Size by Country/Region (2019-2024)
4.2.1 Global Continuous Glucose Monitoring (CGM) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Continuous Glucose Monitoring (CGM) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Continuous Glucose Monitoring (CGM) Sales Growth
4.4 APAC Continuous Glucose Monitoring (CGM) Sales Growth
4.5 Europe Continuous Glucose Monitoring (CGM) Sales Growth
4.6 Middle East & Africa Continuous Glucose Monitoring (CGM) Sales Growth
5 Americas
5.1 Americas Continuous Glucose Monitoring (CGM) Sales by Country
5.1.1 Americas Continuous Glucose Monitoring (CGM) Sales by Country (2019-2024)
5.1.2 Americas Continuous Glucose Monitoring (CGM) Revenue by Country (2019-2024)
5.2 Americas Continuous Glucose Monitoring (CGM) Sales by Type
5.3 Americas Continuous Glucose Monitoring (CGM) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Continuous Glucose Monitoring (CGM) Sales by Region
6.1.1 APAC Continuous Glucose Monitoring (CGM) Sales by Region (2019-2024)
6.1.2 APAC Continuous Glucose Monitoring (CGM) Revenue by Region (2019-2024)
6.2 APAC Continuous Glucose Monitoring (CGM) Sales by Type
6.3 APAC Continuous Glucose Monitoring (CGM) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Continuous Glucose Monitoring (CGM) by Country
7.1.1 Europe Continuous Glucose Monitoring (CGM) Sales by Country (2019-2024)
7.1.2 Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2019-2024)
7.2 Europe Continuous Glucose Monitoring (CGM) Sales by Type
7.3 Europe Continuous Glucose Monitoring (CGM) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Continuous Glucose Monitoring (CGM) by Country
8.1.1 Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Continuous Glucose Monitoring (CGM) Revenue by Country (2019-2024)
8.2 Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Type
8.3 Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Continuous Glucose Monitoring (CGM)
10.3 Manufacturing Process Analysis of Continuous Glucose Monitoring (CGM)
10.4 Industry Chain Structure of Continuous Glucose Monitoring (CGM)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Continuous Glucose Monitoring (CGM) Distributors
11.3 Continuous Glucose Monitoring (CGM) Customer
12 World Forecast Review for Continuous Glucose Monitoring (CGM) by Geographic Region
12.1 Global Continuous Glucose Monitoring (CGM) Market Size Forecast by Region
12.1.1 Global Continuous Glucose Monitoring (CGM) Forecast by Region (2025-2030)
12.1.2 Global Continuous Glucose Monitoring (CGM) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Continuous Glucose Monitoring (CGM) Forecast by Type
12.7 Global Continuous Glucose Monitoring (CGM) Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.1.3 Pfizer Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.2.3 Baxter Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.3.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 Medtronic
13.4.1 Medtronic Company Information
13.4.2 Medtronic Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.4.3 Medtronic Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Medtronic Main Business Overview
13.4.5 Medtronic Latest Developments
13.5 Animas
13.5.1 Animas Company Information
13.5.2 Animas Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.5.3 Animas Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Animas Main Business Overview
13.5.5 Animas Latest Developments
13.6 Novo Nordisk
13.6.1 Novo Nordisk Company Information
13.6.2 Novo Nordisk Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.6.3 Novo Nordisk Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Novo Nordisk Main Business Overview
13.6.5 Novo Nordisk Latest Developments
13.7 Ypsomed
13.7.1 Ypsomed Company Information
13.7.2 Ypsomed Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.7.3 Ypsomed Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Ypsomed Main Business Overview
13.7.5 Ypsomed Latest Developments
13.8 GlySens
13.8.1 GlySens Company Information
13.8.2 GlySens Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.8.3 GlySens Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 GlySens Main Business Overview
13.8.5 GlySens Latest Developments
14 Research Findings and Conclusion
List Of Tables
List of Tables
Table 1. Continuous Glucose Monitoring (CGM) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Continuous Glucose Monitoring (CGM) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Transmitters
Table 4. Major Players of Sensors
Table 5. Major Players of Insulin Pumps
Table 6. Global Continuous Glucose Monitoring (CGM) Sales by Type (2019-2024) & (K Units)
Table 7. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2019-2024)
Table 8. Global Continuous Glucose Monitoring (CGM) Revenue by Type (2019-2024) & ($ million)
Table 9. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Type (2019-2024)
Table 10. Global Continuous Glucose Monitoring (CGM) Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Continuous Glucose Monitoring (CGM) Sales by Application (2019-2024) & (K Units)
Table 12. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2019-2024)
Table 13. Global Continuous Glucose Monitoring (CGM) Revenue by Application (2019-2024)
Table 14. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Application (2019-2024)
Table 15. Global Continuous Glucose Monitoring (CGM) Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Continuous Glucose Monitoring (CGM) Sales by Company (2019-2024) & (K Units)
Table 17. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Company (2019-2024)
Table 18. Global Continuous Glucose Monitoring (CGM) Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Company (2019-2024)
Table 20. Global Continuous Glucose Monitoring (CGM) Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Continuous Glucose Monitoring (CGM) Producing Area Distribution and Sales Area
Table 22. Players Continuous Glucose Monitoring (CGM) Products Offered
Table 23. Continuous Glucose Monitoring (CGM) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Continuous Glucose Monitoring (CGM) Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Continuous Glucose Monitoring (CGM) Sales Market Share Geographic Region (2019-2024)
Table 28. Global Continuous Glucose Monitoring (CGM) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Continuous Glucose Monitoring (CGM) Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Country/Region (2019-2024)
Table 32. Global Continuous Glucose Monitoring (CGM) Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Continuous Glucose Monitoring (CGM) Sales by Country (2019-2024) & (K Units)
Table 35. Americas Continuous Glucose Monitoring (CGM) Sales Market Share by Country (2019-2024)
Table 36. Americas Continuous Glucose Monitoring (CGM) Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Continuous Glucose Monitoring (CGM) Revenue Market Share by Country (2019-2024)
Table 38. Americas Continuous Glucose Monitoring (CGM) Sales by Type (2019-2024) & (K Units)
Table 39. Americas Continuous Glucose Monitoring (CGM) Sales by Application (2019-2024) & (K Units)
Table 40. APAC Continuous Glucose Monitoring (CGM) Sales by Region (2019-2024) & (K Units)
Table 41. APAC Continuous Glucose Monitoring (CGM) Sales Market Share by Region (2019-2024)
Table 42. APAC Continuous Glucose Monitoring (CGM) Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Continuous Glucose Monitoring (CGM) Revenue Market Share by Region (2019-2024)
Table 44. APAC Continuous Glucose Monitoring (CGM) Sales by Type (2019-2024) & (K Units)
Table 45. APAC Continuous Glucose Monitoring (CGM) Sales by Application (2019-2024) & (K Units)
Table 46. Europe Continuous Glucose Monitoring (CGM) Sales by Country (2019-2024) & (K Units)
Table 47. Europe Continuous Glucose Monitoring (CGM) Sales Market Share by Country (2019-2024)
Table 48. Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Continuous Glucose Monitoring (CGM) Revenue Market Share by Country (2019-2024)
Table 50. Europe Continuous Glucose Monitoring (CGM) Sales by Type (2019-2024) & (K Units)
Table 51. Europe Continuous Glucose Monitoring (CGM) Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Continuous Glucose Monitoring (CGM) Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Continuous Glucose Monitoring (CGM) Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Continuous Glucose Monitoring (CGM)
Table 59. Key Market Challenges & Risks of Continuous Glucose Monitoring (CGM)
Table 60. Key Industry Trends of Continuous Glucose Monitoring (CGM)
Table 61. Continuous Glucose Monitoring (CGM) Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Continuous Glucose Monitoring (CGM) Distributors List
Table 64. Continuous Glucose Monitoring (CGM) Customer List
Table 65. Global Continuous Glucose Monitoring (CGM) Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Continuous Glucose Monitoring (CGM) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Continuous Glucose Monitoring (CGM) Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Continuous Glucose Monitoring (CGM) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Continuous Glucose Monitoring (CGM) Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Continuous Glucose Monitoring (CGM) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Continuous Glucose Monitoring (CGM) Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Continuous Glucose Monitoring (CGM) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Continuous Glucose Monitoring (CGM) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Continuous Glucose Monitoring (CGM) Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Continuous Glucose Monitoring (CGM) Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Continuous Glucose Monitoring (CGM) Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Continuous Glucose Monitoring (CGM) Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Pfizer Basic Information, Continuous Glucose Monitoring (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
Table 81. Pfizer Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. Baxter Basic Information, Continuous Glucose Monitoring (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 85. Baxter Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
Table 86. Baxter Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Baxter Main Business
Table 88. Baxter Latest Developments
Table 89. Abbott Laboratories Basic Information, Continuous Glucose Monitoring (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 90. Abbott Laboratories Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
Table 91. Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Abbott Laboratories Main Business
Table 93. Abbott Laboratories Latest Developments
Table 94. Medtronic Basic Information, Continuous Glucose Monitoring (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 95. Medtronic Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
Table 96. Medtronic Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Medtronic Main Business
Table 98. Medtronic Latest Developments
Table 99. Animas Basic Information, Continuous Glucose Monitoring (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 100. Animas Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
Table 101. Animas Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Animas Main Business
Table 103. Animas Latest Developments
Table 104. Novo Nordisk Basic Information, Continuous Glucose Monitoring (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 105. Novo Nordisk Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
Table 106. Novo Nordisk Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Novo Nordisk Main Business
Table 108. Novo Nordisk Latest Developments
Table 109. Ypsomed Basic Information, Continuous Glucose Monitoring (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 110. Ypsomed Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
Table 111. Ypsomed Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Ypsomed Main Business
Table 113. Ypsomed Latest Developments
Table 114. GlySens Basic Information, Continuous Glucose Monitoring (CGM) Manufacturing Base, Sales Area and Its Competitors
Table 115. GlySens Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
Table 116. GlySens Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. GlySens Main Business
Table 118. GlySens Latest Developments
List of Figures
Figure 1. Picture of Continuous Glucose Monitoring (CGM)
Figure 2. Continuous Glucose Monitoring (CGM) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Continuous Glucose Monitoring (CGM) Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Continuous Glucose Monitoring (CGM) Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Continuous Glucose Monitoring (CGM) Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Transmitters
Figure 10. Product Picture of Sensors
Figure 11. Product Picture of Insulin Pumps
Figure 12. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Type in 2023
Figure 13. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Type (2019-2024)
Figure 14. Continuous Glucose Monitoring (CGM) Consumed in Hospitals
Figure 15. Global Continuous Glucose Monitoring (CGM) Market: Hospitals (2019-2024) & (K Units)
Figure 16. Continuous Glucose Monitoring (CGM) Consumed in Homecare Settings
Figure 17. Global Continuous Glucose Monitoring (CGM) Market: Homecare Settings (2019-2024) & (K Units)
Figure 18. Continuous Glucose Monitoring (CGM) Consumed in Others
Figure 19. Global Continuous Glucose Monitoring (CGM) Market: Others (2019-2024) & (K Units)
Figure 20. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2023)
Figure 21. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Application in 2023
Figure 22. Continuous Glucose Monitoring (CGM) Sales Market by Company in 2023 (K Units)
Figure 23. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Company in 2023
Figure 24. Continuous Glucose Monitoring (CGM) Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Company in 2023
Figure 26. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Continuous Glucose Monitoring (CGM) Sales 2019-2024 (K Units)
Figure 29. Americas Continuous Glucose Monitoring (CGM) Revenue 2019-2024 ($ Millions)
Figure 30. APAC Continuous Glucose Monitoring (CGM) Sales 2019-2024 (K Units)
Figure 31. APAC Continuous Glucose Monitoring (CGM) Revenue 2019-2024 ($ Millions)
Figure 32. Europe Continuous Glucose Monitoring (CGM) Sales 2019-2024 (K Units)
Figure 33. Europe Continuous Glucose Monitoring (CGM) Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Continuous Glucose Monitoring (CGM) Revenue 2019-2024 ($ Millions)
Figure 36. Americas Continuous Glucose Monitoring (CGM) Sales Market Share by Country in 2023
Figure 37. Americas Continuous Glucose Monitoring (CGM) Revenue Market Share by Country in 2023
Figure 38. Americas Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2019-2024)
Figure 39. Americas Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2019-2024)
Figure 40. United States Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Continuous Glucose Monitoring (CGM) Sales Market Share by Region in 2023
Figure 45. APAC Continuous Glucose Monitoring (CGM) Revenue Market Share by Regions in 2023
Figure 46. APAC Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2019-2024)
Figure 47. APAC Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2019-2024)
Figure 48. China Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Continuous Glucose Monitoring (CGM) Sales Market Share by Country in 2023
Figure 56. Europe Continuous Glucose Monitoring (CGM) Revenue Market Share by Country in 2023
Figure 57. Europe Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2019-2024)
Figure 58. Europe Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2019-2024)
Figure 59. Germany Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Continuous Glucose Monitoring (CGM) Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2019-2024)
Figure 68. Egypt Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Continuous Glucose Monitoring (CGM) Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Continuous Glucose Monitoring (CGM) in 2023
Figure 74. Manufacturing Process Analysis of Continuous Glucose Monitoring (CGM)
Figure 75. Industry Chain Structure of Continuous Glucose Monitoring (CGM)
Figure 76. Channels of Distribution
Figure 77. Global Continuous Glucose Monitoring (CGM) Sales Market Forecast by Region (2025-2030)
Figure 78. Global Continuous Glucose Monitoring (CGM) Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Continuous Glucose Monitoring (CGM) Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Continuous Glucose Monitoring (CGM) Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Continuous Glucose Monitoring (CGM) Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Continuous Glucose Monitoring (CGM) Revenue Market Share Forecast by Application (2025-2030)
Companies Mentioned
Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens
Methodology
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Data Sourse
Primary Source
Secondary Source
Players/Suppliers
Journals and Periodicals
Industry Experts
Government Bodies
Distributors/Traders
Annual Reports
Opinion Leaders
Presentations
Front-line Staff
Paid Databases
Marketing Executives
LPI Internal Repository
Data Analysis
Data Synthesis
Data Validation
Information Gathering
Triangulation with Data Models
Collation of Data
Reference Against Proprietary
Estimation of Key Figures
Databases
Analysis of Derived Insights
Corroboration with Industry Experts
Writing And Finishing Report
Qualitative Analysis
Qualitative Analysis
Market drivers
Market size and forecast
Market challenges
Market segmentation
Market trends
Geographical insights
Five forces analysis
Competitive landscape
Have A Question?
Provide comprehensive and accurate analysis and reports according to your exact requirements.
Contact Us
Select A Format
Single User License
USD3660
Multi Users License
USD5490
Corporate Users License
USD7320
Buy Now
Add To Cart
Or More Options：
PDF Download
Sample Request
Custom Request
Jump To Content
Description
Table Of Contents
List Of Tables
Companies Mentioned
Methodology
Have A Question?
Provide comprehensive and accurate analysis and reports according to your exact requirements.
Contact Us
17890 Castleton St. Suite 162 City of Industry, CA 91748 United States
Copyright © 2016-2025 LP Information All Rights Reserved
